0 1

Cited 0 times in

Diabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention

DC Field Value Language
dc.contributor.author조성수-
dc.date.accessioned2025-06-27T02:23:59Z-
dc.date.available2025-06-27T02:23:59Z-
dc.date.issued2025-03-
dc.identifier.issn1936-8798-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/205947-
dc.description.abstractBackground: A heightened prothrombotic environment, combined with premature and more aggressive atherosclerosis, contributes to the elevated cardiovascular risk in patients with diabetes mellitus (DM). Objectives: The aim of this study was to evaluate the association between DM status and thrombogenicity and their prognostic implications in patients with significant coronary artery disease. Methods: A total of 2,501 patients with coronary artery disease undergoing percutaneous coronary intervention, with on-admission glycated hemoglobin and thrombogenicity indexes (measured by thromboelastography). Major adverse cardiovascular events (MACE) were defined as a composite of all-cause death, myocardial infarction, or stroke within 4-year follow-up. Results: Patients with DM (n = 970 [38.8%]) demonstrated significantly higher platelet-fibrin clot strength (PFCS), as indicated by maximal amplitude (median [Q1-Q3]: 67.1 [62.2-72.2] mm vs. 65.5 [61.0-70.4] mm; P < 0.001), and reduced fibrinolytic activity, measured by lysis at 30 minutes (median [Q1-Q3]: 0.1% [0.0%-1.0%] vs. 0.2% [0.0%-1.3%]; P = 0.003), compared to patients without DM. PFCS level was closely related with diabetic status, showing a positive relationship with glycated hemoglobin level up to 7.0% and then reaching a plateau. In a multivariable analysis, high PFCS phenotype defined as maximal amplitude ≥68 mm (HR: 1.39; 95% CI: 1.07-1.81; P = 0.015) and DM phenotype (HR: 1.38; 95% CI: 1.05-1.79; P = 0.018) were independently associated with MACE occurrence. The presence of diabetic phenotype and high PFCS exhibited an additive effect on MACE occurrence (HR: 2.49; 95% CI: 1.77-3.51; P < 0.001). Conclusions: In percutaneous coronary intervention-treated patients, diabetic status and clot-strength value were significantly correlated. High clot-strength phenotype increased the risk for MACE, irrespective of diabetic phenotype. (Gyeongsang National University Hospital Registry [GNUH]; NCT04650529).-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfJACC-CARDIOVASCULAR INTERVENTIONS-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAged-
dc.subject.MESHBiomarkers / blood-
dc.subject.MESHBlood Coagulation*-
dc.subject.MESHCoronary Artery Disease* / blood-
dc.subject.MESHCoronary Artery Disease* / diagnosis-
dc.subject.MESHCoronary Artery Disease* / diagnostic imaging-
dc.subject.MESHCoronary Artery Disease* / mortality-
dc.subject.MESHCoronary Artery Disease* / therapy-
dc.subject.MESHCoronary Thrombosis* / blood-
dc.subject.MESHCoronary Thrombosis* / etiology-
dc.subject.MESHCoronary Thrombosis* / mortality-
dc.subject.MESHDiabetes Mellitus* / blood-
dc.subject.MESHDiabetes Mellitus* / diagnosis-
dc.subject.MESHDiabetes Mellitus* / mortality-
dc.subject.MESHFemale-
dc.subject.MESHFibrinolysis-
dc.subject.MESHGlycated Hemoglobin / metabolism-
dc.subject.MESHHumans-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPercutaneous Coronary Intervention* / adverse effects-
dc.subject.MESHPercutaneous Coronary Intervention* / mortality-
dc.subject.MESHRisk Assessment-
dc.subject.MESHRisk Factors-
dc.subject.MESHThrombelastography-
dc.subject.MESHTime Factors-
dc.subject.MESHTreatment Outcome-
dc.titleDiabetic Status and Thrombogenicity: Association and Prognostic Implications After Percutaneous Coronary Intervention-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorSungsoo Cho-
dc.contributor.googleauthorMoonki Jung-
dc.contributor.googleauthorJong-Hwa Ahn-
dc.contributor.googleauthorMin Gyu Kang-
dc.contributor.googleauthorJae Seok Bae-
dc.contributor.googleauthorJin-Sin Koh-
dc.contributor.googleauthorSeok-Jae Hwang-
dc.contributor.googleauthorHwi Seung Kim-
dc.contributor.googleauthorSang-Wook Kim-
dc.contributor.googleauthorJin-Yong Hwang-
dc.contributor.googleauthorYoung-Hoon Jeong-
dc.identifier.doi10.1016/j.jcin.2024.12.002-
dc.contributor.localIdA03833-
dc.relation.journalcodeJ01193-
dc.identifier.eissn1876-7605-
dc.identifier.pmid40139850-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S1936879824018181-
dc.subject.keywordcardiovascular event-
dc.subject.keywordclot strength-
dc.subject.keywordcoronary artery disease-
dc.subject.keyworddiabetes mellitus-
dc.subject.keywordpercutaneous coronary intervention-
dc.contributor.alternativeNameCho, Sung Soo-
dc.contributor.affiliatedAuthor조성수-
dc.citation.volume18-
dc.citation.number6-
dc.citation.startPage720-
dc.citation.endPage733-
dc.identifier.bibliographicCitationJACC-CARDIOVASCULAR INTERVENTIONS, Vol.18(6) : 720-733, 2025-03-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.